This study is recruiting. It focuses on depression and currently lists participation information in the United States.
This study is looking at whether High Touch Outreach can help people with Lung Cancer, Anxiety, or Depression in. Participants take part in High Touch Outreach and complete follow-up assessments. Taking part may give some people access to High Touch Outreach, but direct benefit is not guaranteed.
The official record suggests a mix of remote and in-person participation through a university, with sites including Abramson Cancer Center at the University of Pennsylvania in Philadelphia. Participation appears to involve study activities and check-ins designed to see how this approach works in practice. The main fit is usually having a stable enough treatment background for the study, while common reasons not to take part include other treatments that could interfere with the study and major medical issues that could make participation unsuitable. The official record does not list a formal phase, which usually means this is focused more on feasibility, delivery, or support than a standard drug-development stage.
This study may matter because it adds public evidence around depression. HopeStage presents it as a starting point for understanding the study, checking the official source, and preparing questions with a care team.
This page links back to the public source record so people can verify details directly with the registry and research team.
If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.
Open source recordThis form records your interest so HopeStage can follow up with practical guidance. It is not a medical eligibility decision and it does not guarantee a study spot.
Taking part may help test a support approach in real life.
It requires regular follow-up, often through questionnaires or interviews.
Mixes in-person and remote participation.
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
This study is exploring behavioral or lifestyle intervention for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed.
This study is sponsored by Abramson Cancer Center at Penn Medicine. Based on the sponsor name or official registry information, it appears to be a pharmaceutical company. You should verify the details in the official registry record.
This study may involve behavioral or lifestyle intervention, study visits, and assessments. The time commitment is multiple visits or assessments. The study phase is not available in HopeStage data. Check the official source record to see whether a phase is listed. Enrollment is not available in HopeStage data. HopeStage cannot say whether a study is safe or right for you. Before joining, ask the research team about possible risks, time commitment, visits, side effects, compensation, safety monitoring, and whether participation may affect your current care.
Use the official source record linked on this page to check the full study description, recruitment status, eligibility criteria, locations, sponsor information, phase, enrollment, contact details, and any listed risks or requirements.